Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KREBS BIOCHEMICALS vs VIVIMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KREBS BIOCHEMICALS VIVIMED LABS KREBS BIOCHEMICALS/
VIVIMED LABS
 
P/E (TTM) x -7.5 -0.1 - View Chart
P/BV x - 1.0 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KREBS BIOCHEMICALS   VIVIMED LABS
EQUITY SHARE DATA
    KREBS BIOCHEMICALS
Mar-23
VIVIMED LABS
Mar-23
KREBS BIOCHEMICALS/
VIVIMED LABS
5-Yr Chart
Click to enlarge
High Rs19017 1,093.8%   
Low Rs517 766.1%   
Sales per share (Unadj.) Rs24.222.6 107.2%  
Earnings per share (Unadj.) Rs-11.5-39.6 28.9%  
Cash flow per share (Unadj.) Rs-8.4-26.5 31.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-46.14.8 -970.2%  
Shares outstanding (eoy) m21.5682.91 26.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.00.5 935.9%   
Avg P/E ratio x-10.5-0.3 3,469.9%  
P/CF ratio (eoy) x-14.3-0.5 3,165.8%  
Price / Book Value ratio x-2.62.5 -103.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,599997 260.8%   
No. of employees `000NANA-   
Total wages/salary Rs m155327 47.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5211,871 27.9%  
Other income Rs m610 64.0%   
Total revenues Rs m5281,881 28.1%   
Gross profit Rs m-158-1,870 8.4%  
Depreciation Rs m661,084 6.1%   
Interest Rs m30362 8.2%   
Profit before tax Rs m-247-3,307 7.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-21 -0.0%   
Profit after tax Rs m-247-3,285 7.5%  
Gross profit margin %-30.3-99.9 30.3%  
Effective tax rate %00.6 -0.0%   
Net profit margin %-47.4-175.6 27.0%  
BALANCE SHEET DATA
Current assets Rs m1613,323 4.8%   
Current liabilities Rs m4914,243 11.6%   
Net working cap to sales %-63.4-49.2 128.9%  
Current ratio x0.30.8 41.8%  
Inventory Days Days53389 13.5%  
Debtors Days Days37150 24.5%  
Net fixed assets Rs m1,5896,561 24.2%   
Share capital Rs m216166 130.0%   
"Free" reserves Rs m-1,210228 -529.9%   
Net worth Rs m-995394 -252.3%   
Long term debt Rs m1,732623 278.0%   
Total assets Rs m1,7509,883 17.7%  
Interest coverage x-7.3-8.1 89.9%   
Debt to equity ratio x-1.71.6 -110.2%  
Sales to assets ratio x0.30.2 157.4%   
Return on assets %-12.4-29.6 42.0%  
Return on equity %24.8-833.4 -3.0%  
Return on capital %-29.4-289.4 10.2%  
Exports to sales %00.9 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA17 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m017 0.0%   
Fx outflow Rs m50-   
Net fx Rs m-517 -32.6%   
CASH FLOW
From Operations Rs m-247353 -70.0%  
From Investments Rs m-126-50 254.5%  
From Financial Activity Rs m373-338 -110.6%  
Net Cashflow Rs m0-34 0.4%  

Share Holding

Indian Promoters % 72.7 20.9 347.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 1.8 28.4%  
FIIs % 0.5 1.6 29.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 27.3 79.1 34.5%  
Shareholders   8,909 49,027 18.2%  
Pledged promoter(s) holding % 0.0 37.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KREBS BIOCHEMICALS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on KREBS BIOCHEMICALS vs VIVIMED LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KREBS BIOCHEMICALS vs VIVIMED LABS Share Price Performance

Period KREBS BIOCHEMICALS VIVIMED LABS S&P BSE HEALTHCARE
1-Day 1.30% -3.92% -0.25%
1-Month 9.22% -10.42% 0.39%
1-Year 0.37% -52.88% 52.67%
3-Year CAGR -14.19% -22.63% 14.16%
5-Year CAGR -7.28% -38.72% 19.21%

* Compound Annual Growth Rate

Here are more details on the KREBS BIOCHEMICALS share price and the VIVIMED LABS share price.

Moving on to shareholding structures...

The promoters of KREBS BIOCHEMICALS hold a 72.7% stake in the company. In case of VIVIMED LABS the stake stands at 20.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KREBS BIOCHEMICALS and the shareholding pattern of VIVIMED LABS.

Finally, a word on dividends...

In the most recent financial year, KREBS BIOCHEMICALS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

VIVIMED LABS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of KREBS BIOCHEMICALS, and the dividend history of VIVIMED LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 22,400 | Tejas Networks Rallies 10% Sensex Today Trades Higher | Nifty Above 22,400 | Tejas Networks Rallies 10%(10:30 am)

Asian markets traded higher on Tuesday following overnight gain on Wall Street.